TL;DR: Cigna Healthcare modified MM 0540 for ablative treatment of malignant breast tumors, effective October 16, 2025. CPT codes 0581T, 0971T, and 19499 are all designated not medically necessary under this coverage policy. Here's what billing teams need to do before claims go out the door.
Cigna Healthcare updated its ablative breast tumor coverage policy under MM 0540, and the position is blunt: cryoablation, percutaneous laser ablation, microwave thermotherapy, and radiofrequency ablation for malignant breast tumors are not medically necessary. Every code in this policy — 0581T, 0971T, and 19499 — lands in the "not medically necessary" bucket. If your practice bills these procedures for Cigna members, expect claim denial without a strong appeal strategy in place.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Ablative Treatment for Malignant Breast Tumor — MM 0540 |
| Policy Code | MM 0540 |
| Change Type | Modified |
| Effective Date | October 16, 2025 |
| Impact Level | High |
| Specialties Affected | Surgical oncology, breast surgery, interventional radiology, general surgery |
| Key Action | Flag 0581T, 0971T, and 19499 in your charge capture as non-covered for Cigna; review any pending claims before October 16, 2025 |
Cigna Ablative Breast Tumor Coverage Criteria and Medical Necessity Requirements 2025
The Cigna ablative breast tumor coverage policy under MM 0540 draws a hard line. Cigna does not consider any of the four addressed ablative modalities — cryoablation, percutaneous laser ablation, microwave thermotherapy, or radiofrequency ablation — to meet the standard of medical necessity for treating malignant breast tumors.
This isn't a "covered with conditions" policy. There are no clinical criteria that unlock reimbursement. There is no prior authorization pathway that gets these procedures approved. The coverage position is a flat denial for the indication as a whole.
The three CPT codes in scope — 0581T for percutaneous cryotherapy ablation of malignant breast tumors, 0971T for percutaneous laser ablation of malignant breast tumors, and 19499 as an unlisted breast procedure code — all carry the same group designation: "Considered Not Medically Necessary."
This matters for billing teams because 19499 is the wildcard here. Unlisted procedure codes get used when nothing else fits. If a provider performs a breast ablation procedure and someone on your team reaches for 19499 hoping to get reimbursement through a manual review, Cigna's position on MM 0540 makes that a losing bet. Document it, but don't expect payment.
Cigna Ablative Breast Tumor Exclusions and Non-Covered Indications
Under MM 0540 in the Cigna system, all four ablative modalities covered by this policy are excluded from coverage for malignant breast tumors. That's the full scope of this coverage policy.
Cryoablation uses extreme cold to destroy tumor tissue. Cigna considers this not medically necessary for breast malignancies. CPT 0581T, which includes imaging guidance when performed, is specifically called out.
Percutaneous laser ablation uses focused laser energy to destroy tumor cells. CPT 0971T, also inclusive of imaging guidance when performed, is not covered. This is a newer Category III code, and Cigna's position reflects where most commercial payers land on emerging ablative technologies — skeptical until trial data matures.
Microwave thermotherapy uses microwave energy to heat and destroy tumor tissue. No specific CPT code for microwave thermotherapy appears in the MM 0540 code table, which means billing falls to the unlisted procedure code 19499. That code is also not covered.
Radiofrequency ablation (RFA) of breast tumors follows the same path — no specific CPT code listed in this policy, same unlisted code outcome.
The real issue here is that these modalities are frequently used and discussed in breast cancer treatment conversations, especially for patients who aren't surgical candidates. Patients may arrive with expectations. Providers may perform the procedure. But Cigna will not pay for it under the current MM 0540 policy.
If your clinical team is exploring ablative techniques for breast tumors in Cigna-insured patients, loop in your compliance officer before those cases are scheduled. This isn't a gray area — it's a documented non-coverage position.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Cryoablation of malignant breast tumor | Not Medically Necessary | 0581T | Includes imaging guidance; no prior auth pathway available |
| Percutaneous laser ablation of malignant breast tumor | Not Medically Necessary | 0971T | Category III code; includes imaging guidance; flat denial |
| Microwave thermotherapy for malignant breast tumor | Not Medically Necessary | 19499 | No specific CPT; unlisted code used; still non-covered |
| Radiofrequency ablation of malignant breast tumor | Not Medically Necessary | 19499 | No specific CPT; unlisted code used; still non-covered |
Cigna Ablative Breast Tumor Billing Guidelines and Action Items 2025
The effective date is October 16, 2025. These steps apply to any Cigna member encounters involving ablative breast procedures at or after that date — and you should audit any pending claims now.
| # | Action Item |
|---|---|
| 1 | Flag 0581T, 0971T, and 19499 in your charge capture for Cigna payer rules. Set these codes to trigger a warning when billed with a Cigna payer ID. Your team should know before the claim goes out that Cigna will deny it. |
| 2 | Pull any claims for 0581T, 0971T, or 19499 that are pending or in the queue before October 16, 2025. Evaluate whether those claims should be held, modified, or sent with an appeal package ready to go. Don't let them age into denials without a plan. |
| 3 | Update your patient financial counseling workflow for Cigna members. If a provider is recommending cryoablation or laser ablation for a breast tumor, the patient needs to understand before the procedure that Cigna will not cover it. Get financial consent documented. Ablative breast tumor billing disputes are much harder to resolve after the fact. |
| 4 | Build a denial management protocol specific to MM 0540. When Cigna denies claims under this policy, appeals need to cite peer-reviewed clinical literature supporting the procedure's safety and efficacy. Your appeal pathway should include physician attestation, published trial data, and a clear argument for why the standard of medical necessity is met for the individual patient. This won't work in every case, but a documented appeal process is better than a write-off. |
| 5 | Watch 0971T specifically. This is a Category III CPT code, which means it's already on payer watch lists as an emerging technology. Category III codes often carry blanket non-coverage positions across commercial payers. Check your other commercial payer contracts for similar positions on 0971T — Cigna's stance here often signals where the rest of the market is heading. |
| 6 | Talk to your compliance officer if you have high volume on these procedures. If your practice has significant volume of ablative breast procedures in a Cigna-heavy market, this policy has real revenue exposure. Your compliance officer should know about the MM 0540 Cigna position before the October 16 effective date, not after a denial spike shows up in your denial dashboard. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Ablative Breast Tumor Treatment Under MM 0540
All three CPT codes under MM 0540 carry a "Considered Not Medically Necessary" designation. There are no covered indications in this policy.
Not Covered / Not Medically Necessary Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 0581T | CPT | Ablation, malignant breast tumor(s), percutaneous, cryotherapy, including imaging guidance when performed | Considered Not Medically Necessary |
| 0971T | CPT | Ablation, malignant breast tumor(s), percutaneous, laser, including imaging guidance when performed | Considered Not Medically Necessary |
| 19499 | CPT | Unlisted procedure, breast | Considered Not Medically Necessary |
No ICD-10-CM diagnosis codes are specified in the MM 0540 policy data. The non-coverage position applies to the procedures themselves for malignant breast tumor indications, regardless of the specific diagnosis code billed alongside them.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.